Zichen Luo

35 papers receiving 550 citations

Peers

Zichen Luo
Comparison fields: 5 of 94
  • Biological Psychiatry 13
  • Pharmacology 37
  • Biotechnology 36
  • Molecular Biology 263
  • Molecular Medicine 16
Replace Hadi Ghaffari with:
Hadi Ghaffari Iran
Xuemeng Ji China
Tae‐Su Jang South Korea
Eman Sheta Egypt
Kuan-Chen Cheng Taiwan
Meisam Barati Iran
Liming Lin China
Ehssan Moglad Saudi Arabia
Chunmei Hu China
Bahman Khalvati Iran
Zichen Luo relative to Hadi Ghaffari Iran Hadi Ghaffari's profile →
Citations per field
00.5×
Hadi Ghaffari · 1×
Citations per year

Countries citing papers authored by Zichen Luo

Since Specialization
Citations

This map shows the geographic impact of Zichen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zichen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zichen Luo more than expected).

Fields of papers citing papers by Zichen Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zichen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zichen Luo. The network helps show where Zichen Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Zichen Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zichen Luo Line = papers co-authored together Zichen Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202256
2 202049
3 201938
4 202336
5 202331
6 202329
7 202129
8 202326
9 202226
10 202223
11 202019
12 201319
13 201418
14 202017
15 202217
16 202314
17 202313
18 202312
19 202312
20 201411

About Zichen Luo

Zichen Luo is a scholar working on Pharmacology, Pharmacology, Hepatology, Biotechnology and Immunology and Allergy, having authored 44 papers that have together received 559 indexed citations. Recurring topics across this work include Ginseng Biological Effects and Applications (5 papers), Gut microbiota and health (5 papers), Biofuel production and bioconversion (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Respiratory viral infections research (3 papers), Microbial Metabolic Engineering and Bioproduction (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Biological Psychiatry (13 citations), Pharmacology (37 citations), Biotechnology (36 citations), Molecular Biology (263 citations) and Molecular Medicine (16 citations). Zichen Luo has collaborated with scholars based in China and United States. Frequent co-authors include Jinjun Shan, Renqiang Yu, Jie Bao, Ying Zhang, Shanyu Jiang, Jianjian Ji, Ailing Chen, Weichen Xu, Liuqing Di and Yang‐Tian Yan. Their work appears in journals such as Phytomedicine, Journal of Pharmaceutical and Biomedical Analysis, Frontiers in Immunology, Journal of Ethnopharmacology and Frontiers in Cellular and Infection Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026